Indian Generic Players Begin Price War Over Generic Empagliflozin Launches
The Launches Follow The Expiry of Boehringer’s Patents For The Blockbuster Drug
Eyeing the lucrative opportunity, three Indian players have launched their generic versions of Boehringer’s anti-diabetes drug Jardiance in their domestic market.
